These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7559568)

  • 1. Interaction of the transcriptional activator Stat-2 with the type I interferon receptor.
    Uddin S; Chamdin A; Platanias LC
    J Biol Chem; 1995 Oct; 270(42):24627-30. PubMed ID: 7559568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.
    Colamonici O; Yan H; Domanski P; Handa R; Smalley D; Mullersman J; Witte M; Krishnan K; Krolewski J
    Mol Cell Biol; 1994 Dec; 14(12):8133-42. PubMed ID: 7526154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the intracellular domain of the human type I interferon receptor 2 chain (IFNAR2c) in interferon signaling. Expression of IFNAR2c truncation mutants in U5A cells.
    Russell-Harde D; Wagner TC; Rani MR; Vogel D; Colamonici O; Ransohoff RM; Majchrzak B; Fish E; Perez HD; Croze E
    J Biol Chem; 2000 Aug; 275(31):23981-5. PubMed ID: 10825167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proximal tyrosines of the cytoplasmic domain of the beta chain of the type I interferon receptor are essential for signal transducer and activator of transcription (Stat) 2 activation. Evidence that two Stat2 sites are required to reach a threshold of interferon alpha-induced Stat2 tyrosine phosphorylation that allows normal formation of interferon-stimulated gene factor 3.
    Nadeau OW; Domanski P; Usacheva A; Uddin S; Platanias LC; Pitha P; Raz R; Levy D; Majchrzak B; Fish E; Colamonici OR
    J Biol Chem; 1999 Feb; 274(7):4045-52. PubMed ID: 9933596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
    Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR
    J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Configuration of the interferon-alpha/beta receptor complex determines the context of the biological response.
    Ghislain J; Sussman G; Goelz S; Ling LE; Fish EN
    J Biol Chem; 1995 Sep; 270(37):21785-92. PubMed ID: 7665599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein.
    Yan H; Krishnan K; Greenlund AC; Gupta S; Lim JT; Schreiber RD; Schindler CW; Krolewski JJ
    EMBO J; 1996 Mar; 15(5):1064-74. PubMed ID: 8605876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-alpha-stimulated transcription factor ISGF3.
    Martinez-Moczygemba M; Gutch MJ; French DL; Reich NC
    J Biol Chem; 1997 Aug; 272(32):20070-6. PubMed ID: 9242679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 activation by type I interferons is dependent on specific tyrosines located in the cytoplasmic domain of interferon receptor chain 2c. Activation of multiple STATS proceeds through the redundant usage of two tyrosine residues.
    Velichko S; Wagner TC; Turkson J; Jove R; Croze E
    J Biol Chem; 2002 Sep; 277(38):35635-41. PubMed ID: 12105218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
    Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
    Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.
    Uddin S; Majchrzak B; Wang PC; Modi S; Khan MK; Fish EN; Platanias LC
    Biochem Biophys Res Commun; 2000 Apr; 270(1):158-62. PubMed ID: 10733921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities.
    Subramaniam PS; Khan SA; Pontzer CH; Johnson HM
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12270-4. PubMed ID: 8618883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-alpha activates signal transducers and activators of transcription 5 and 6 in Daudi cells.
    Fasler-Kan E; Pansky A; Wiederkehr M; Battegay M; Heim MH
    Eur J Biochem; 1998 Jun; 254(3):514-9. PubMed ID: 9688261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins.
    David M; Petricoin E; Benjamin C; Pine R; Weber MJ; Larner AC
    Science; 1995 Sep; 269(5231):1721-3. PubMed ID: 7569900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
    Sancéau J; Hiscott J; Delattre O; Wietzerbin J
    Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Members of the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway are present and active in human sperm.
    D'Cruz OJ; Vassilev AO; Uckun FM
    Fertil Steril; 2001 Aug; 76(2):258-66. PubMed ID: 11476770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
    Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
    Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.
    Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME
    J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2.
    Platanias LC; Uddin S; Yetter A; Sun XJ; White MF
    J Biol Chem; 1996 Jan; 271(1):278-82. PubMed ID: 8550573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of genomic DNA affinity chromatography identifies multiple interferon-alpha-regulated Stat2 complexes.
    Ghislain JJ; Fish EN
    J Biol Chem; 1996 May; 271(21):12408-13. PubMed ID: 8647845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.